Research & Policy

Corporate stories about Research & Policy across 3BL's network.

Latest in Research & Policy

Increasing Diversity in Clinical Trials: A Collaboration with Tufts Center for the Study of Drug Development
At Biogen, we are committed to putting the weight of our business, our employees, and our collaboration partners to help close the disparity gap in clinical trials and access to healthcare.
#BacktheFrontline: Joe Wolk, Executive Vice President, Chief Financial Officer, Johnson & Johnson
Learn more about how we #BackTheFrontline by investing in innovators developing scalable solutions to COVID-19 from Johnson & Johnson Impact Ventures Chair Joe Wolk.
Johnson & Johnson Announces European Commission Approval for Janssen's Preventive Ebola Vaccine
On July 1, Johnson & Johnson announced that the European Commission (EC) has granted Marketing Authorisation for its Janssen Pharmaceutical Companies’ Ebola vaccine regimen for the prevention of Ebola Virus Disease.
Following Emergency Pandemic Response, the Tomorrow Rising Fund by the Schneider Electric Foundation Focuses Support on Recovery and Resiliency
Two months after launching the Tomorrow Rising fund to support Covid-19 emergency relief in April 2020, Schneider Electric’s Foundation moves forward to support recovery and resiliency through education and training programs.
In Praise of Paper Ballots
From concerns around vote hacking to the fear of exposure to COVID-19, states are under increased scrutiny about how they will handle this year’s election. There is one thing that provides a good solution for both concerns – paper.
An Open Letter from Daniel O'Day, Chairman & CEO, Gilead Sciences
After receiving the green light from the FDA to move forward, Gilead is about to start trials of an inhaled version of remdesivir. We will screen healthy volunteers for Phase 1 trials this week and hope to begin studies in patients with COVID-19...
Cancer Immunotherapy Awareness Month™ at Alkermes
Along with the Society for Immunotherapy of Cancer we strive for a future #Immune2Cancer because to our team, cancer immunotherapy research is personal.
BSR
A Human Rights-Based Approach to COVID-19 Decision-Making
BSR has developed three primers on how to respect human rights during the COVID-19 crisis: one for the energy and extractives sector; one for the food, beverage, and agriculture sector; and one for the transportation and logistics sector.
People Feel Unsafe Using Public Restrooms with Air Dryers, New Study Finds
According to a study from Tork on the impact of COVID-19 on people’s perception of public hygiene, 86% believe keeping a high hygiene standard in public restrooms is critical to public safety.
On the Record: AJC Journalists on Covering COVID
Connecting our communities with accurate, in-depth information has never been more important than it is now and will be in the days to come.

Latest Campaigns

Health and Safety by Antea Group

Antea Group's health and safety consultants understand what it takes to help make a positive impact on safety culture. Read blogs, insights, and more...

Wesco Cares

Life-changing events can happen to any of us, often when we least expect them. Employees in need can turn to the Wesco Cares. Its mission is to be an...

People

As a family-owned business, Bacardi values the importance of creating a warm and welcoming workplace. We do so by fostering an environment where...

Collaboration and Partnership

Cascale shares updates on its strategic partnerships with industry stakeholders geared toward shifting the industry into one that gives back more than...

Sustainable Products and Innovation

Ongoing research into innovative solutions enables CNH’s brands to manufacture products that respect the environment while satisfying customers’...

Education

Our technology is playing a vital role in helping educators inspire students and boost achievement. Learn more here.

Prescription for a Better World

Prescription for a Better World defines CVS Health's CSR strategy and is aligned to support the company’s purpose of helping people on their path to...